Cargando…

Exploring the Therapeutic Potential of Ethyl 3-Hydroxybutyrate in Alleviating Skeletal Muscle Wasting in Cancer Cachexia

Cachexia (CAC) is a debilitating metabolic syndrome. Although dietary interventions are attractive, long-term adherence to specific diets is difficult to maintain and can lead to systemic side effects. Ethyl 3-hydroxybutyrate (EHB) is a commonly used food additive found in wine and Tribolium castane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yu, Lu, Ruohan, Lin, Fusheng, Chen, Shu, He, Qi-Qing, Wu, Guoyang, Huang, Caihua, Lin, Donghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527383/ https://www.ncbi.nlm.nih.gov/pubmed/37759730 http://dx.doi.org/10.3390/biom13091330

Ejemplares similares

Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release
por: Zhou, Lin, et al.
Publicado: (2021)

Metabolic derangements of skeletal muscle from a murine model of glioma cachexia
por: Cui, Pengfei, et al.
Publicado: (2019)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

Metabolomics and its Applications in Cancer Cachexia
por: Cui, Pengfei, et al.
Publicado: (2022)

Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
por: Rausch, Valentina, et al.
Publicado: (2021)

Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response
por: Guo, Dunwei, et al.
Publicado: (2017)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Lenk, Karsten, et al.
Publicado: (2010)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Bowen, T Scott, et al.
Publicado: (2015)

MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia
por: Marceca, Gioacchino P., et al.
Publicado: (2020)

β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations
por: Wei, Shao, et al.
Publicado: (2022)

Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia
por: Song, Juquan, et al.
Publicado: (2021)

STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2011)

Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1
por: Tao, Weili, et al.
Publicado: (2023)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Mathematical Model of Muscle Wasting in Cancer Cachexia
por: Farhang-Sardroodi, Suzan, et al.
Publicado: (2020)

Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021)

Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia
por: Ojima, Chiharu, et al.
Publicado: (2020)

Taurine Protects C2C12 Myoblasts From Impaired Cell Proliferation and Myotube Differentiation Under Cisplatin-Induced ROS Exposure
por: Zhou, Lin, et al.
Publicado: (2021)

Research on cachexia, sarcopenia and skeletal muscle in cardiology
por: Coats, Andrew J. S.
Publicado: (2012)

2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle
por: Wei, Lulu, et al.
Publicado: (2022)

FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
por: Neyroud, Daria, et al.
Publicado: (2021)

β-Hydroxybutyrate Elicits Favorable Mitochondrial Changes in Skeletal Muscle
por: Parker, Brian A., et al.
Publicado: (2018)

The Skeletal Muscle as an Active Player Against Cancer Cachexia
por: Penna, Fabio, et al.
Publicado: (2019)

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020)

Phosphorylation of Dynamin-Related Protein 1 (DRP1) Regulates Mitochondrial Dynamics and Skeletal Muscle Wasting in Cancer Cachexia
por: Mao, Xiangyu, et al.
Publicado: (2021)

Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass
por: Sakuma, Kunihiro, et al.
Publicado: (2012)

Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective
por: Khan, Bushra, et al.
Publicado: (2023)

Metabolomic Analysis of Trehalose Alleviating Oxidative Stress in Myoblasts
por: Zhang, Shuya, et al.
Publicado: (2023)

Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia
por: Miao, Chunxiao, et al.
Publicado: (2021)

The role of insulin resistance in the development of muscle wasting during cancer cachexia
por: Honors, Mary A., et al.
Publicado: (2011)

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
por: Ábrigo, Johanna, et al.
Publicado: (2018)

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
por: Chiappalupi, Sara, et al.
Publicado: (2020)

NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy
por: Kong, Qing, et al.
Publicado: (2022)

NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy
por: Kong, Qing, et al.
Publicado: (2022)

NMR-Based Metabolomic Analysis for the Effects of Trimethylamine N-Oxide Treatment on C2C12 Myoblasts under Oxidative Stress
por: Zou, Hong, et al.
Publicado: (2022)

β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy
por: Kim, Yerin, et al.
Publicado: (2023)

Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle
por: Johns, Neil, et al.
Publicado: (2014)

The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia
por: VanderVeen, Brandon N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_liuspiimrsm39n546l1sqfdrjs